<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04877353</url>
  </required_header>
  <id_info>
    <org_study_id>NIV _COPD</org_study_id>
    <nct_id>NCT04877353</nct_id>
  </id_info>
  <brief_title>Postoperative Noninvasive Ventilation After Upper Abdominal Surgery in Chronic Obstructive Lung Disease</brief_title>
  <official_title>Postoperative Noninvasive Ventilation After Upper Abdominal Surgery in Chronic Obstructive Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Valley University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Valley University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In Qena university hospital a prospective, randomized study was carried out on 100 COPD&#xD;
      patients, all were divided into; conventional therapy without NIV (C group) 50 patients or&#xD;
      with prophylactic NIV(N group) 50 patients.NIV applied for approximately 30 to 45 min at 2-&#xD;
      to 4-h intervals for 48 h following surgery . Primary endpoint was the acute respiratory&#xD;
      events (ARE) .Secondary endpoints were acute respiratory failure (ARF), intubation rate,&#xD;
      mortality rate, infectious and non-infectious complications, and ICU stay.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">November 15, 2020</completion_date>
  <primary_completion_date type="Actual">March 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Postoperative NIV</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acute respiratory events</measure>
    <time_frame>28days</time_frame>
    <description>patients %</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>acute respiratory failure</measure>
    <time_frame>28 days</time_frame>
    <description>patients %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intubation rate</measure>
    <time_frame>28 days</time_frame>
    <description>patients %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>28 days</time_frame>
    <description>patients %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>28 days</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infectious and non infectious complications</measure>
    <time_frame>28 days</time_frame>
    <description>patients %</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Acute Respiratory Failure Post Surgical (Diagnosis)</condition>
  <arm_group>
    <arm_group_label>Group N</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 patients.NIV applied for approximately 30 to 45 min at 2- to 4-h intervals for 48 h following surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group C</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>50 patients recieved conventional oxygen therpy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NIV</intervention_name>
    <description>NIV applied for approximately 30 to 45 min at 2- to 4-h intervals for 48 h following surgery</description>
    <arm_group_label>Group N</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        1. Inclusion criteria:&#xD;
&#xD;
               -  AgeËƒ18 years, scheduled for upper abdominal surgery under general anesthesia.&#xD;
&#xD;
               -  Moderate to very severe COPD (GOLD II to IV).&#xD;
&#xD;
               -  ASA functional status II or greater.&#xD;
&#xD;
          2. Exclusion criteria:&#xD;
&#xD;
               -  Contraindications to the application of NIV.&#xD;
&#xD;
               -  Sleep apnea syndrome.&#xD;
&#xD;
               -  Facial deformation.&#xD;
&#xD;
               -  Inability to follow the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>asmaa Mostafa</name>
      <address>
        <city>Luxor</city>
        <zip>85951</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>May 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Valley University</investigator_affiliation>
    <investigator_full_name>Asmaa Mohamed</investigator_full_name>
    <investigator_title>PhD candidate _anesthesia ,ICU &amp;pain management_Qena SVU</investigator_title>
  </responsible_party>
  <keyword>noninvasive ventilation</keyword>
  <keyword>COPD</keyword>
  <keyword>acute respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

